|
|
 |
Ultravist® | | | General Information | |
| Vendor | | Berlex Inc. | | Item | | Ultravist® | | Features | | Head and body contrast-enhanced computed tomography
Excretory urography
Coronary arteriography and left ventriculography
Aortography and visceral angiography
Cerebral arteriography
Peripheral venography
Intra-arterial digital subtraction angiography | | Approval | | FDA | | Product Number | | 50419-342-05 | | Contrast For | | CECT | | Unit | | Box of 10 | | Container | | 240 mgI/mL 100ml - 200ml | | Dosage | | Not to Exceed 250 mL | | Osmolality | | 240 mgI/mL-483 @ 37°C | | Viscosity | | 240 mgI/mL-2.8 @ 37°C | | Pricing |  | Inquire | | Financing | | To finance this purchase click here (U.S. customers only) |
| | Product Description | |
| ULTRAVIST® (iopromide) injection is a nonionic, iodinated, low-osmolar radiological contrast agent for intravascular administration. Introduced in the U.S. in 1995, ten years after becoming available in Europe, ULTRAVIST® today is used in over 75 countries. It has established a positive clinical experience in more than 60 million patients worldwide. | |
| Berlex Inc. | | Customer Service: (510) 262-5000 | | Web site: http://www.berlex.com | |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
